Laboratórios Baldacci S.A   Report issue

For profit Phase 3
Founded: Sao Paulo Brazil (1951)
Status: No NME R&D (1951)

Organization Overview

First Clinical Trial
2014
NCT02152579
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

isosorbide (isordil) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Angina Pectoris (Phase 3)

Angina, Stable (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1